Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-β1 from the extracellular matrix of growth plate chondrocytes

Endocrinology

Volumn 140, Issue 12, 1999, Pages 5806-5816

  Pedrozo, H A ^a   Schwartz, Z ^a,c   Robinson, M ^a   Gomez, R ^a   Dean, D D ^a   Bonewald, L F ^a,b   Boyan, B D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Hadassah Faculty of Dental Medicine ^*  (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GROWTH PLATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0033305426     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.12.7224     Document Type: Article

References (41)

1. 3
2. The production of transforming growth factor-β by chick growth plate chondrocytes in short term monolayer culture
3. Transforming growth factor-β
4. Direct effects of transforming growfh factor-β on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner
5. 3
6. 3 metabolites regulate LTBP1 and latent TGF-β1 expression and latent TGF-β1 incorporation in the extracellular matrix of chondrocytes
7. Latent forms of transforming growth factor-β (TGFβ) derived from bone cultures: Identification of a naturally occurring 100 kDa complex with similarity to recombinant latent TGFβ
8. Growth plate chondrocytes store latent TGF-β1 in their matrix through latent TGFβ binding protein
9. Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast-like cell lines
10. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGFβ binding protein
11. Characterization and regulation of the latent transforming growth factor-β (TGF-β) complex secreted by vascular pericytes
12. Latent high molecular weight complex of transforming growth factor β1. Purification from human platelets and structural characterization
13. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β
14. Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein
15. Fibrillin, a new 350 kD glycoprotein, is a component of extracellular microfibrils
16. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils
17. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices
18. Type 1 transforming growth factor β: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells
19. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system
20. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1
21. Thrombospondin-1 is a major activator of TGF-β1 in vivo
22. The integrin αvβ6 binds and activates latent TGFβ1: A mechanism for regulating pulmonary inflammation and fibrosis
23. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner
24. Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro
25. In vitro studies on the regulation of endochondral ossification by vitamin D
26. 3
27. The synergistic effects of vitamin D metabolites and TGFβ on costochondral chondrocytes are mediated by increases in protein kinase C activity involving two separate pathways
28. Trasylol
29. The influence of synthetic thrombin inhibitors on the thrombin-antithrombin reaction
30. A coupled protometric assay for plasminogen activator
31. Mechanisms of activation of latent recombinant transforming growth factor-β by plasmin
32. Release of transforming growth factor-β1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin
33. 3 metabolites
34. 3 on resting zone chondrocytes in metabolite-specific and mediated by PKC
35. Serum transforming growth factor-β 1 is related to the degree of immunoparesis in patients with multiple myeloma
36. Transforming growth factor-β1 in plasma and liver of children with liver disease
37. Activation of latent transforming growth factor β during chlamydia trachomatis-induced routine pneumonia
38. 2 production, in human synovial fibroblasts
39. Role of latent TGFβ1 binding protein in the activation of latent TGFβ in co-cultures of endothelial and smooth muscle cells
40. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned media
41. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor β that can be activated by neural crest cell proteolysis